Long-term control and partial remission after initial pseudoprogression of glioblastoma by anti–PD-1 treatment with nivolumab
P Roth, A Valavanis, M Weller - Neuro-oncology, 2017 - academic.oup.com
P Roth, A Valavanis, M Weller
Neuro-oncology, 2017•academic.oup.comLong-term control and partial remission after initial pseudoprogression of glioblastoma by
anti–PD-1 treatment with nivolumab Page 1 454 Letters to the Editor the surgical specimen
precludes the possibility of neuropathological assessment of invasion and leads to a second
question: “should pathologists report the presence/absence of brain tissue with which to assess
invasion?” Previous studies have shown that extensive and systematic surgical sampling in
combination with thorough histopathology assessment increases reporting of brain invasion.Here …
anti–PD-1 treatment with nivolumab Page 1 454 Letters to the Editor the surgical specimen
precludes the possibility of neuropathological assessment of invasion and leads to a second
question: “should pathologists report the presence/absence of brain tissue with which to assess
invasion?” Previous studies have shown that extensive and systematic surgical sampling in
combination with thorough histopathology assessment increases reporting of brain invasion.Here …
Long-term control and partial remission after initial pseudoprogression of glioblastoma by anti–PD-1 treatment with nivolumab
Oxford University Press